세계의 페노바르비탈 시장 보고서(2025년)

Phenobarbital is a long-acting barbiturate medication primarily used to control and prevent seizures, especially in the treatment of epilepsy. It is occasionally prescribed as a sedative for anxiety or to manage withdrawal symptoms. It works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve activity in the brain, leading to a calming effect on the central nervous system and a reduced risk of seizures.

The main indications for phenobarbital are epilepsy and neonatal seizures. Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. It is available in various dosage forms such as tablets, capsules, and injectables, and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies. It is used in seizure management, anesthesia, sleep disorders, and alcohol withdrawal syndrome, serving a range of end users, including hospitals, clinics, research laboratories, and homecare settings.

The phenobarbital market research report is one of a series of new reports from The Business Research Company that provides phenobarbital market statistics, including phenobarbital industry global market size, regional shares, competitors with a phenobarbital market share, detailed phenobarbital market segments, market trends and opportunities, and any further data you may need to thrive in the phenobarbital industry. This phenobarbital market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The phenobarbital market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to the widespread use in epilepsy management, the prevalence of epilepsy and seizure disorders, government supply programs, increasing demand in veterinary applications, and efforts toward achieving universal health coverage.

The phenobarbital market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth during the forecast period can be linked to the expansion of generic drug manufacturing, growing focus on neurological disease management, digital supply chain and e-pharmacy growth, regulatory changes favoring generic use, and stability in regulatory pathways for generics. Key trends in the forecast period include the development of easy-to-administer delivery forms, innovation in research and development, extended-release formulations, enhanced drug delivery systems, and investments in improving production techniques.

The rising prevalence of epilepsy is anticipated to drive the growth of the phenobarbital market. Epilepsy is a neurological condition marked by recurring, unprovoked seizures caused by abnormal brain activity. The increasing incidence of epilepsy is partly due to greater awareness, leading more individuals to recognize symptoms and seek medical attention, resulting in more reported cases. Phenobarbital, an anticonvulsant medication, helps control seizures by slowing down the activity of neurons in the brain. For example, a report from the Centers for Disease Control and Prevention (CDC) in May 2024 revealed that between 2021 and 2022, around 2.9 million adults in the U.S. were living with active epilepsy, representing approximately 1% of the adult population. As a result, the growing prevalence of epilepsy is expected to drive the demand for phenobarbital.

Key companies in the phenobarbital market are focusing on developing new treatments, such as phenobarbital sodium, to improve both the safety and effectiveness of therapies. Phenobarbital sodium is the sodium salt form of phenobarbital, commonly used as an anticonvulsant and sedative. It is primarily prescribed to manage seizures, especially in conditions such as epilepsy, and can also be used to treat anxiety, insomnia, and to induce sedation before medical procedures. In January 2023, Sun Pharmaceutical Industries Ltd., an India-based pharmaceutical company, launched SEZABY (phenobarbital sodium) in the U.S. This was the first FDA-approved medication specifically designed to treat seizures in both term and preterm neonates. SEZABY is free of benzyl alcohol and propylene glycol, making it safer for use in newborns. The drug received orphan drug designation and is supported by clinical data demonstrating its effectiveness in controlling neonatal seizures, addressing a critical unmet need in this vulnerable patient group.

In November 2022, Sun Pharmaceutical Industries Ltd. partnered with SPARC, an India-based biopharmaceutical company, to commercialize phenobarbital for injection in the U.S. This collaboration focuses on marketing a benzyl alcohol- and propylene glycol-free phenobarbital sodium injection to address the unmet need for an FDA-approved treatment for neonatal seizures, while also reducing the risk of neonatal gasping syndrome. SPARC specializes in developing innovative therapeutics.

Major players in the phenobarbital market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, H. Lundbeck A/S, Sandoz Group AG, Yashiro Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Par Pharmaceutical Inc., Shandong Xinhua Pharmaceutical Co. Ltd., Manus Aktteva Biopharma LLP, JPN Pharma Pvt. Ltd., Alkaloida Chemical Company Zrt., Harman Finochem Ltd.

North America was the largest region in the phenobarbital market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in phenobarbital report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the phenobarbital market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phenobarbital market consists of sales of products including phenobarbital tablets, phenobarbital oral elixir, phenobarbital injectables, veterinary phenobarbital products, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Phenobarbital Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on phenobarbital market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for phenobarbital ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The phenobarbital market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Indication: Epilepsy; Neonatal Seizures
• 2) By Dosage Forms: Tablets; Capsules; Injectables
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By Application: Seizure Management; Anesthesia; Sleep Disorders; Alcohol Withdrawal Syndrome
• 5) By End User: Hospitals; Clinics; Research Laboratories; Homecare Settings
• Subsegments:
• 1) By Epilepsy: Focal (Partial) Seizures; Generalized Tonic-Clonic Seizures; Status Epilepticus; Refractory Epilepsy; Idiopathic Epilepsy
• 2) By Neonatal Seizures: Hypoxic-Ischemic Encephalopathy (HIE)-Induced Seizures; Intracranial Hemorrhage-Induced Seizures; Metabolic Disorders; Congenital Brain Malformations; Infections
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Eli Lilly and Company; Baxter International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Phenobarbital Market Characteristics

3. Phenobarbital Market Trends And Strategies

4. Phenobarbital Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Phenobarbital Growth Analysis And Strategic Analysis Framework

• 5.1. Global Phenobarbital PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Phenobarbital Market Growth Rate Analysis
• 5.4. Global Phenobarbital Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Phenobarbital Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Phenobarbital Total Addressable Market (TAM)

6. Phenobarbital Market Segmentation

• 6.1. Global Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epilepsy
• Neonatal Seizures
• 6.2. Global Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injectables
• 6.3. Global Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Phenobarbital Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Seizure Management
• Anesthesia
• Sleep Disorders
• Alcohol Withdrawal Syndrome
• 6.5. Global Phenobarbital Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Laboratories
• Homecare Settings
• 6.6. Global Phenobarbital Market, Sub-Segmentation Of Epilepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Focal (Partial) Seizures
• Generalized Tonic-Clonic Seizures
• Status Epilepticus
• Refractory Epilepsy
• Idiopathic Epilepsy
• 6.7. Global Phenobarbital Market, Sub-Segmentation Of Neonatal Seizures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypoxic-Ischemic Encephalopathy (HIE)-Induced Seizures
• Intracranial Hemorrhage-Induced Seizures
• Metabolic Disorders
• Congenital Brain Malformations
• Infections

7. Phenobarbital Market Regional And Country Analysis

• 7.1. Global Phenobarbital Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Phenobarbital Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Phenobarbital Market

• 8.1. Asia-Pacific Phenobarbital Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Phenobarbital Market

• 9.1. China Phenobarbital Market Overview
• 9.2. China Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Phenobarbital Market

• 10.1. India Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Phenobarbital Market

• 11.1. Japan Phenobarbital Market Overview
• 11.2. Japan Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Phenobarbital Market

• 12.1. Australia Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Phenobarbital Market

• 13.1. Indonesia Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Phenobarbital Market

• 14.1. South Korea Phenobarbital Market Overview
• 14.2. South Korea Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Phenobarbital Market

• 15.1. Western Europe Phenobarbital Market Overview
• 15.2. Western Europe Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Phenobarbital Market

• 16.1. UK Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Phenobarbital Market

• 17.1. Germany Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Phenobarbital Market

• 18.1. France Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Phenobarbital Market

• 19.1. Italy Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Phenobarbital Market

• 20.1. Spain Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Phenobarbital Market

• 21.1. Eastern Europe Phenobarbital Market Overview
• 21.2. Eastern Europe Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Phenobarbital Market

• 22.1. Russia Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Phenobarbital Market

• 23.1. North America Phenobarbital Market Overview
• 23.2. North America Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Phenobarbital Market

• 24.1. USA Phenobarbital Market Overview
• 24.2. USA Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Phenobarbital Market

• 25.1. Canada Phenobarbital Market Overview
• 25.2. Canada Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Phenobarbital Market

• 26.1. South America Phenobarbital Market Overview
• 26.2. South America Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Phenobarbital Market

• 27.1. Brazil Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Phenobarbital Market

• 28.1. Middle East Phenobarbital Market Overview
• 28.2. Middle East Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Phenobarbital Market

• 29.1. Africa Phenobarbital Market Overview
• 29.2. Africa Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Phenobarbital Market Competitive Landscape And Company Profiles

• 30.1. Phenobarbital Market Competitive Landscape
• 30.2. Phenobarbital Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Phenobarbital Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Fresenius Kabi AG
• 31.3. Sun Pharmaceutical Industries Ltd.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Lupin Limited
• 31.6. H. Lundbeck A/S
• 31.7. Sandoz Group AG
• 31.8. Yashiro Pharmaceutical Co. Ltd.
• 31.9. Hikma Pharmaceuticals PLC
• 31.10. Par Pharmaceutical Inc.
• 31.11. Shandong Xinhua Pharmaceutical Co. Ltd.
• 31.12. Manus Aktteva Biopharma LLP
• 31.13. JPN Pharma Pvt. Ltd.
• 31.14. Alkaloida Chemical Company Zrt.
• 31.15. Harman Finochem Ltd.

32. Global Phenobarbital Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Phenobarbital Market

34. Recent Developments In The Phenobarbital Market

35. Phenobarbital Market High Potential Countries, Segments and Strategies

• 35.1 Phenobarbital Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Phenobarbital Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Phenobarbital Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer